Bio-Rad Laboratories Inc - Asset Resilience Ratio
Bio-Rad Laboratories Inc (BIO-B) has an Asset Resilience Ratio of 10.80% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BIO-B current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2003–2025)
This chart shows how Bio-Rad Laboratories Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Bio-Rad Laboratories Inc (BIO-B) total assets.
Liquid Assets Composition Over Time
This chart breaks down Bio-Rad Laboratories Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Bio-Rad Laboratories Inc to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.06 Billion | 10.8% |
| Total Liquid Assets | $1.06 Billion | 10.80% |
Asset Resilience Insights
- Moderate Liquidity: Bio-Rad Laboratories Inc has 10.80% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Bio-Rad Laboratories Inc Industry Peers by Asset Resilience Ratio
Compare Bio-Rad Laboratories Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Bio-Rad Laboratories Inc (2003–2025)
The table below shows the annual Asset Resilience Ratio data for Bio-Rad Laboratories Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.56% | $1.01 Billion | $10.58 Billion | -3.00pp |
| 2024-12-31 | 12.56% | $1.18 Billion | $9.36 Billion | +2.78pp |
| 2023-12-31 | 9.78% | $1.20 Billion | $12.30 Billion | -0.26pp |
| 2022-12-31 | 10.05% | $1.36 Billion | $13.50 Billion | +7.80pp |
| 2021-12-31 | 2.24% | $399.13 Million | $17.80 Billion | -0.29pp |
| 2020-12-31 | 2.54% | $328.91 Million | $12.97 Billion | -3.13pp |
| 2019-12-31 | 5.67% | $453.97 Million | $8.01 Billion | -1.70pp |
| 2018-12-31 | 7.37% | $413.27 Million | $5.61 Billion | -1.32pp |
| 2017-12-31 | 8.69% | $371.15 Million | $4.27 Billion | -1.27pp |
| 2016-12-31 | 9.95% | $383.18 Million | $3.85 Billion | +1.09pp |
| 2015-12-31 | 8.86% | $328.72 Million | $3.71 Billion | +0.35pp |
| 2014-12-31 | 8.51% | $284.38 Million | $3.34 Billion | +0.33pp |
| 2013-12-31 | 8.18% | $277.37 Million | $3.39 Billion | -5.11pp |
| 2012-12-31 | 13.29% | $457.69 Million | $3.44 Billion | +5.58pp |
| 2011-12-31 | 7.71% | $238.88 Million | $3.10 Billion | +3.84pp |
| 2010-12-31 | 3.87% | $118.64 Million | $3.06 Billion | +0.13pp |
| 2009-12-31 | 3.74% | $94.88 Million | $2.54 Billion | +1.83pp |
| 2008-12-31 | 1.91% | $38.95 Million | $2.04 Billion | -1.23pp |
| 2007-12-31 | 3.14% | $61.98 Million | $1.97 Billion | -13.43pp |
| 2006-12-31 | 16.57% | $264.47 Million | $1.60 Billion | +8.41pp |
| 2005-12-31 | 8.16% | $116.34 Million | $1.43 Billion | -3.94pp |
| 2004-12-31 | 12.10% | $165.90 Million | $1.37 Billion | +3.71pp |
| 2003-12-31 | 8.39% | $83.25 Million | $992.60 Million | -- |
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more